The serious shortlist for international residential treatment, for most clients researching it carefully, narrows quickly. There are facilities in Switzerland and South Africa and Costa Rica and a handful of other destinations, but in the actual decisions families make, the comparison usually comes down to three: Thailand, Bali, and Mexico. They are the destinations with the deepest infrastructure for international clients, the most consistent clinical quality at the upper tiers, and the most established track records over the past decade.

The honest answer to which is right is not the same for every client. Each destination has a real character, a particular clinical strength, and a set of trade-offs that matter more for some presentations than others. This piece is for families weighing the three seriously rather than reflexively.

Thailand: The Established Standard

The global picture matters. The UN Office on Drugs and Crime’s 2024 World Drug Report documents that an estimated 292 million people used drugs in 2022 — a 20 percent increase over the previous decade — while access to evidence-based treatment continues to lag well behind need.

Thailand has been a meaningful destination for international residential addiction treatment since the early 2000s, and the depth of that history shows in the maturity of the sector. The major facilities are licensed by the Thai Ministry of Public Health under a regulatory framework that requires clinical staffing, facility standards, and documented outcomes. Senior clinicians at the better Thai programs are typically dual-qualified, with credentials in their countries of origin and additional Thai licensure for practising on-shore.

The clinical strengths of Thai treatment, where the better programs are concerned, are the integration of evidence-based addiction medicine with somatic and trauma-focused modalities, the presence of established 12-step community alongside non-12-step alternatives, and a meaningful track record with complex dual-diagnosis presentations. The setting itself — coastal islands and inland mountains, depending on the program — adds a contemplative dimension that the work itself benefits from.

Cost is the second strong argument. Thai residential programs of high clinical quality run from approximately US$10,000 to US$18,000 for 28 days, with Holina specifically in the US$9,700 to US$17,700 range depending on accommodation tier. This is 40 to 70 percent less than equivalent care in the UK, US, or Australia, with no compromise on clinical depth.

The relative weaknesses, where they exist, are travel time from Europe and the Americas (typically 15 to 30 hours door-to-door) and the unfamiliarity of Thai culture and climate for some clients. Neither is generally a barrier, but both warrant honest weighing.

Thailand suits clients with moderate to severe dependence, those with significant trauma backgrounds, those who have cycled through local treatment without sustained gain, and those for whom cost is a meaningful variable in the decision.

Bali: The Wellness-Forward Alternative

Bali emerged as a residential treatment destination roughly a decade after Thailand, and the sector there carries the imprint of that later arrival — newer facilities, a stronger orientation toward wellness and yoga-adjacent modalities, and a clientele that skews slightly younger and more wellness-fluent on average than the Thai equivalent.

The clinical strengths of the better Balinese programs include strong somatic and movement-based work, integration of Indonesian and broader Asian wellness traditions, and a particular fit for clients whose entry point to recovery has been through wellness and consciousness practices rather than through 12-step or strictly clinical frames. Several Balinese programs do excellent work with eating-related patterns, with cannabis and ketamine presentations among younger clients, and with the post-burnout-into-substance-use trajectory common in tech, creative, and entrepreneurial populations.

Cost in Bali is broadly similar to Thailand, occasionally slightly higher at the top tier of facilities. Regulatory infrastructure is less mature than Thailand’s — there is no single equivalent to the Thai Ministry of Public Health licensure framework — which makes verifying clinical credentials and outcomes more dependent on direct due diligence with the facility. The better programs are very good. The variability between programs is wider than in Thailand.

Travel time from Europe is somewhat longer than to Thailand; from Australia, somewhat shorter. From the US, broadly similar to Thailand.

Bali suits younger adult clients, those whose dependence sits alongside meaningful eating, body-image, or wellness-pattern dynamics, those with backgrounds in conscious or contemplative practice, and those for whom cultural fit with the wellness frame is part of the appeal rather than a neutral feature.

Mexico: The Closer Option for North America

Mexico’s residential treatment sector serves primarily a US and Canadian clientele, and the destination’s primary argument is proximity. A flight from Los Angeles to Cabo or Mazatlán is two and a half hours. A flight from New York to Mexico City is roughly five. For clients in active withdrawal, for families that want to be physically nearer during admission, and for those for whom an 18-hour journey is genuinely prohibitive, Mexico’s geography is a real and material advantage.

The clinical landscape in Mexico is more variable than in either Thailand or Bali. The very best Mexican programs — there are perhaps half a dozen — are excellent, with strong dual-diagnosis capacity, robust medical detox infrastructure, and clinical leadership at the level of any international program. The middle of the market is uneven, and the lower tier is meaningfully riskier than the lower tier in Thailand or Bali. Verifying credentials, licensure, and clinical track record matters more in Mexico than in either of the other two destinations.

Cost in Mexico is broadly comparable to Thailand at the high tier and lower at the middle tier, with the caveat that the lower-cost programs tend to be ones where due diligence is more important rather than less.

Travel time, for North American clients, is the dominant advantage. For European, UK, or Australian clients, Mexico has no particular advantage over Thailand or Bali on travel grounds and is rarely the obvious choice.

Mexico suits North American clients for whom proximity is a genuine variable, those with significant medical complexity warranting closer family presence, and those willing to do thorough due diligence on the specific facility rather than relying on destination reputation alone.

What Actually Differentiates the Choice

In our experience speaking with families weighing the three, the decision is rarely about destination in the abstract. It is about which destination best fits a specific clinical and personal picture. Some honest patterns:

Clients with complex trauma backgrounds, multi-substance presentations, or histories of treatment cycling tend to do best with the depth of clinical infrastructure available in the better Thai and Mexican programs. The somatic and trauma-focused work that these presentations require is well-developed in Thailand specifically.

Younger clients, particularly those whose substance use sits alongside eating-related, body-image, or wellness-pattern dynamics, often find the cultural fit of Bali more aligned with their existing framework for healing. The wellness-forward orientation is genuine in Bali, not cosmetic.

North American clients for whom family proximity, medical complexity, or travel-related anxiety are meaningful variables often find Mexico the better practical choice, provided the specific facility is well-verified.

For most clients with serious dependence, no significant constraint on travel, and a need for the depth of clinical work that produces durable outcomes, Thailand remains the destination with the most mature infrastructure and the most consistent track record. This is not a marketing claim. It is, after speaking with families who have considered all three, the most common pattern we see when the decision is made on clinical grounds rather than convenience.

How To Do the Due Diligence

Regardless of destination, the same questions matter. Licensure of the facility under the relevant national framework. Credentials of senior clinical staff, ideally with continuing licensure in a recognised home country in addition to the local one. Documented clinical methodology rather than vague references to holistic care. Real outcome data, however imperfect, on retention and relapse. Clear, written cost structure with no contingent additions. Reachable references from former clients where appropriate, mindful that anonymity is also legitimate.

A facility that answers these questions clearly and without defensiveness is, in most cases, the kind of place where the work itself will be done well. A facility that deflects, oversells, or promises outcomes is rarely the kind of place where the work is done with integrity, regardless of the destination it sits in.

A Closing Note on the Geography Question

The destination matters less than the program. A well-chosen program in any of the three destinations will, in most cases, produce better outcomes than a poorly-chosen program in a more convenient one. We say this as a Thailand-based facility, because it is also true: the right destination is the one where the right program for the specific client exists, and the work of researching that intersection carefully is itself the work of choosing well.

If you are ready to have that conversation, Holina’s admissions team can speak with you about whether Thailand is the right fit, and will be honest with you if we believe another destination or another program would serve you better. The decision is yours. Our job is to help you make it on the right information.

— Ian Young

Related Reading

• Rehab Abroad Vs Rehab At Home Trade Offs
• Traveling To Thailand Rehab Visa Medication Packing
• Paying For Rehab Without Insurance Thailand Costs